Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Long

Showing results (301-310 of 703) with videos related to

Pageof 71
Sort By:
Pathology|March 7, 2022
Pathologist initiated reflex BRAF mutation testing in metastatic melanoma: experience at a specialist melanoma treatment centreAlison J Potter, Andrew J Colebatch, Robert V Rawson, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|November 3, 2016
Structural and functional 3D mapping of skin tumours with non-invasive multispectral optoacoustic tomographyS Y Chuah, A B E Attia, V Long, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2014
New RAS-mutant pancreatic adenocarcinoma with combined BRAF and MEK inhibition for metastatic melanomaMatteo S Carlino, Vu Kwan, David K Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2026
Lipid Nanoparticle-encapsulated mRNA-2752 Encoding Human OX40L, IL-23, and IL-36γ Plus Durvalumab Induces an Immunostimulatory Effect Within the Tumor Microenvironment in Patients with Advanced Solid TumorsRandy F Sweis, Georgina V Long, Adil Daud, et al.
Clinical Genetics|September 1, 2017
Recessive mutations in NDUFA2 cause mitochondrial leukoencephalopathyS Perrier, L Gauquelin, M Tétreault, et al.
Bioinformatics (Oxford, England)|September 15, 2018
bcGST-an interactive bias-correction method to identify over-represented gene-sets in boutique arraysKevin Y X Wang, Alexander M Menzies, Ines P Silva, et al.
Cancer Research Communications|April 24, 2023
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and RecurrenceEsmee P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, et al.
Viruses|November 27, 2021
Use of Slaughterhouses as Sentinel Points for Genomic Surveillance of Foot-and-Mouth Disease Virus in Southern VietnamUmanga Gunasekara, Miranda R Bertram, Do H Dung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical TrialsAdemi Santiago-Walker, Robert Gagnon, Jolly Mazumdar, et al.
Immunotherapy|May 3, 2023
Health-related quality of life in patients with melanoma brain metastases treated with immunotherapyJake R Thompson, Julia Lai-Kwon, Rachael L Morton, et al.
Pageof 71

Showing results (301-310 of 703) with videos related to

Sort By:
Pageof 71
Pathology|March 7, 2022
Pathologist initiated reflex BRAF mutation testing in metastatic melanoma: experience at a specialist melanoma treatment centreAlison J Potter, Andrew J Colebatch, Robert V Rawson, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|November 3, 2016
Structural and functional 3D mapping of skin tumours with non-invasive multispectral optoacoustic tomographyS Y Chuah, A B E Attia, V Long, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2014
New RAS-mutant pancreatic adenocarcinoma with combined BRAF and MEK inhibition for metastatic melanomaMatteo S Carlino, Vu Kwan, David K Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2026
Lipid Nanoparticle-encapsulated mRNA-2752 Encoding Human OX40L, IL-23, and IL-36γ Plus Durvalumab Induces an Immunostimulatory Effect Within the Tumor Microenvironment in Patients with Advanced Solid TumorsRandy F Sweis, Georgina V Long, Adil Daud, et al.
Clinical Genetics|September 1, 2017
Recessive mutations in NDUFA2 cause mitochondrial leukoencephalopathyS Perrier, L Gauquelin, M Tétreault, et al.
Bioinformatics (Oxford, England)|September 15, 2018
bcGST-an interactive bias-correction method to identify over-represented gene-sets in boutique arraysKevin Y X Wang, Alexander M Menzies, Ines P Silva, et al.
Cancer Research Communications|April 24, 2023
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and RecurrenceEsmee P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, et al.
Viruses|November 27, 2021
Use of Slaughterhouses as Sentinel Points for Genomic Surveillance of Foot-and-Mouth Disease Virus in Southern VietnamUmanga Gunasekara, Miranda R Bertram, Do H Dung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical TrialsAdemi Santiago-Walker, Robert Gagnon, Jolly Mazumdar, et al.
Immunotherapy|May 3, 2023
Health-related quality of life in patients with melanoma brain metastases treated with immunotherapyJake R Thompson, Julia Lai-Kwon, Rachael L Morton, et al.
Pageof 71